146 related articles for article (PubMed ID: 35180653)
1. Characterization of the prognostic and diagnostic values of ALKBH family members in non-small cell lung cancer.
Wang L; Feng X; Jiao Z; Gan J; Meng Q
Pathol Res Pract; 2022 Mar; 231():153809. PubMed ID: 35180653
[TBL] [Abstract][Full Text] [Related]
2. ALKBH family members as novel biomarkers and prognostic factors in human breast cancer.
Chen H; Zhou L; Li J; Hu K
Aging (Albany NY); 2022 Aug; 14(16):6579-6593. PubMed ID: 35980268
[TBL] [Abstract][Full Text] [Related]
3. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
4. ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis.
Wu G; Yan Y; Cai Y; Peng B; Li J; Huang J; Xu Z; Zhou J
Front Cell Dev Biol; 2021; 9():633927. PubMed ID: 34150745
[TBL] [Abstract][Full Text] [Related]
5. Selected ALKBH dioxygenases are overexpressed in salivary gland tumours.
Marcinkowski M; Garbicz D; Pilžys T; Kukwa W; Grzesiuk E
Acta Biochim Pol; 2022 Dec; 69(4):889-894. PubMed ID: 36459535
[TBL] [Abstract][Full Text] [Related]
6. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
7. ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy.
Pilžys T; Marcinkowski M; Kukwa W; Garbicz D; Dylewska M; Ferenc K; Mieczkowski A; Kukwa A; Migacz E; Wołosz D; Mielecki D; Klungland A; Piwowarski J; Poznański J; Grzesiuk E
Sci Rep; 2019 Sep; 9(1):13249. PubMed ID: 31519943
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
[TBL] [Abstract][Full Text] [Related]
9. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
10. Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer.
Fan Y; Gao Z; Li X; Wei S; Yuan K
Bioengineered; 2021 Dec; 12(1):6210-6228. PubMed ID: 34486486
[TBL] [Abstract][Full Text] [Related]
11. Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment.
Song L; Wang X; Cheng W; Wu Y; Liu M; Liu R; Zhang S; Xia H; Liu H; Tai X; Zhao H; Li X; Ji F
BMC Pulm Med; 2021 Dec; 21(1):420. PubMed ID: 34923982
[TBL] [Abstract][Full Text] [Related]
12. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
13. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
15. Novel AlkB dioxygenases--alternative models for in silico and in vivo studies.
Mielecki D; Zugaj DŁ; Muszewska A; Piwowarski J; Chojnacka A; Mielecki M; Nieminuszczy J; Grynberg M; Grzesiuk E
PLoS One; 2012; 7(1):e30588. PubMed ID: 22291995
[TBL] [Abstract][Full Text] [Related]
16. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX; Liu P; Yang J; Wen S
PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract][Full Text] [Related]
18. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
Liu F; Wu H
J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
[TBL] [Abstract][Full Text] [Related]
19. Distinct Prognostic Values of the mRNA Expression of Glucose Transporters in Non-Small Cell Lung Cancer.
Du H; Liu Y; Yuan Y; Zhang Y; Geng H
Ann Clin Lab Sci; 2020 Jul; 50(4):481-489. PubMed ID: 32826245
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.
Zheng X; Wang X; He Y; Ge H
Front Mol Biosci; 2022; 9():844618. PubMed ID: 35923467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
